The Therapeutic Goods Administration has ended a ban on off-label prescriptions of anti-parasitic drug ivermectin, nearly two years after floods of people attempted to procure the drug in the mistaken belief it would treat Covid-19.
The TGA announced on Wednesday it would remove the ban for off-label prescriptions of the drug from 1 June. Off-label prescriptions had been limited to specialists such as dermatologists, gastroenterologists and infectious disease specialists since September 2021.